Silence Therapeutics (SLN)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

530.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 649.00
  • 52 Week Low: 339.00
  • Currency: UK Pounds
  • Shares Issued: 89.74m
  • Volume: 69,390
  • Market Cap: 475.60m
  • RiskGrade: 177

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-21 Interim 5.84 (22.58) (22.80)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 0.77 (10.36) (12.10)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.02 (3.77) (2.30)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (20.53) (26.20)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.24 (22.87) (26.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 5.48 (36.04) (39.80)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 13.04 (39.37) (32.72)p n/a n/a n/a n/a 0.0%
31-Dec-22 24.98 (42.45) (28.88)p n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

SLN Market Data

Currency UK Pounds
Share Price 530.00p
Change Today -22.00p
% Change -3.99 %
52 Week High 649.00
52 Week Low 339.00
Volume 69,390
Shares Issued 89.74m
Market Cap 475.60m
RiskGrade 177

SLN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.45% below the market average43.45% below the market average43.45% below the market average43.45% below the market average43.45% below the market average
56% below the sector average56% below the sector average56% below the sector average56% below the sector average56% below the sector average
Price Trend
13.52% above the market average13.52% above the market average13.52% above the market average13.52% above the market average13.52% above the market average
25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average
Income Not Available
Growth
25.58% above the market average25.58% above the market average25.58% above the market average25.58% above the market average25.58% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 21-Sep-2021

Time Volume / Share Price
17:08 5,001 @ 530.00p
16:35 3,017 @ 530.00p
16:27 3 @ 520.00p
16:27 197 @ 530.00p
16:27 150 @ 530.00p

Top of Page